---
document_datetime: 2023-09-21 21:22:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/glustin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: glustin-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.3600065
conversion_datetime: 2025-12-23 04:42:55.304471
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

## For procedures finalised after 1 October 2003 please refer to module 8B.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

<!-- image -->

| Scope                                                                                                                                                                                                                                                                     | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                                                                               | I/0001               | I                        | 15.11.00                            | -                                       |
| Change in supplier of an intermediate compound used in the manufacture of the active substance Minor change of manufacturing process of the active substance Change in specification of starting material or intermediate used in the manufacture of the active substance | I/0002               | I                        | 04.12.00                            | - authorised                            |
| Change in pack size for a medicinal product                                                                                                                                                                                                                               | I/0003               | I                        | 12.12.00                            | 16.02.01                                |
| Change in or addition of manufacturer(s) of active substance. Change in supplier of an intermediate compound used in manufacture of the active substance. Minor change of manufacturing process of the active substance. Change in test procedure of active substance.    | I/0004               | I                        | 06.04.01                            | -                                       |
| Update of section 5.1 of the Summary of Product Characteristics                                                                                                                                                                                                           | II/0005              | II longer                | 13.12.01                            | 12.04.02                                |
| Change of legal status with the consequent change in section 4.2 of the Summary of Product Characteristics                                                                                                                                                                | II/0006              | II                       | 21.11.02                            | 17.03.03                                |
| Change in or addition of manufacturer(s) of active substance Minor change of manufacturing process of the active substance Change in test procedure of active substance                                                                                                   | I/0007               | I                        | 11.12.02                            | -                                       |
| Increase of the maximum daily dose of pioglitazone to 45 mg                                                                                                                                                                                                               | II/008 no            | II                       | 22.05.03                            | 28.08.03                                |
| Extension of indication for the use of pioglitazone as second line monotherapy                                                                                                                                                                                            | II/009               | II                       | 22.05.03                            | 28.08.03                                |
| Additional strength: tablets of 45 mg                                                                                                                                                                                                                                     | X/0010               | X                        | 26.06.03                            | 16.09.03                                |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

Medicinal Product no longer authorised

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 61(3) of Directive 2001/83/EC of 6 November 2001.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.